Protagonist Therapeutics
PTGX
PTGX
81 hedge funds and large institutions have $164M invested in Protagonist Therapeutics in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
18
Increased
34
Reduced
15
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$12M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.44M |
| 3 |
BlackRock
New York
|
+$3.38M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$1.76M |
| 5 |
O
OrbiMed
New York
|
+$1.35M |
